RISW2026
Back to all people

Dooti Roy

Boehringer Ingelheim Pharmaceuticals, Inc.
3 appearances in the program

Sessions & presentations

PS23: Advancing the Implementation of Safety Methodologies in the Digital Era: An EFSPI/PSI Benefit Risk SIG Safety WG Outreach
Presentation: Quantitative Evolution of Drug Safety: Adapting Inventions to Innovations
Parallel · Thu, Sep 17 , 4:15 PM
Presenting Author
PS14: Efficiency+: Advanced Statistical Innovations Driving Clinical Trial Efficiency
Presentation: Interplay Between Statistical Design and Operational Execution: Points to consider
Parallel · Thu, Sep 17 , 2:45 PM
Presenting Author